Krystal Biotech, Inc. (KRYS)
304.23
+2.18
(+0.72%)
USD |
NASDAQ |
May 21, 16:00
304.23
0.00 (0.00%)
After-Hours: 19:59
Krystal Biotech Research and Development Expense (TTM) : 54.64M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Scholar Rock Holding Corp. | 209.98M |
| TG Therapeutics, Inc. | 162.25M |
| Stoke Therapeutics, Inc. | 143.19M |
| Moderna, Inc. | 2.69B |
| Marker Therapeutics, Inc. | 11.51M |